Announcements

New Report Provides Clear and Clinically Meaningful Results

Interactive report guide

Quickly and easily understand how to interpret the Oncotype DX Breast DCIS Score report.



Only the Oncotype DX Breast DCIS Score report integrates clinicopathological features to provides an individualized risk assessment of 10-year local recurrence for DCIS patients. No other test can help you navigate the complexities of DCIS risk management to personalize your patient's treatment plan.

The Breast DCIS Score report:

  • QUANTIFIES 10-year risk of any local recurrence or an invasive local recurrence
  • CONFIRMED in a meta-analysis involving 773 patients
  • REFINED risk estimates with specified clinicopathologic features
  • INCREASES clarity and confidence in your patient's personalized treatment plan
  •  

    Oncotype DX Breast DCIS Score Report and Meta-Analysis Overview

    Our Director of Medical Affairs explains how the addition of tumor size and patient age increases the prognostic power of the Breast DCIS Score.

     

    Start Report Guide
    Start Report Guide
    Start Report Guide

    Do You Have a Question?

    Contact Us

    Meta-Analysisa

    Rakovitch et al. pooled data from 2 validation studies to refine estimates of local recurrence based on age and tumor size.

    Read Full Text

    Stay in Touch

    Have a specific question? Want to keep up with our latest news? We're here for you.

    Contact Us
    Making cancer care smarter.™